Share this article
Share this article
ResearchAndMarkets.com s offering.
This report features an extensive study of the current market landscape and the future potential of sterile fill/finish services for small molecule drugs. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.
Small molecule drugs account for nearly 90% of the contemporary therapeutics pipeline. In fact, in 2019, the FDA s Center for Drug Evaluation and Research approved 48 small molecule drugs, representing 70% of the new molecular entities (NMEs) clearing regulatory review in the same year. Given that the demand for small molecule drugs is still on the rise, the importance of contract manufacturing and third party services is also increasing in the pharmaceutical industry. Sterile fill/finish is considered among the most crucial steps in the pharmaceutical production process. In fact, aseptic conditions during fill/finish operations are not only esse
reveals that by the end of 2027, close to 35% of global wood pellet sales will be accounted by their end-use in industrial pellet co-firing. In the report, titled “Wood Pellet Market: Global Market Analysis 2012–2016 and Forecast 2012–2027,” the market is expected to reach US$ 9,204.9 Mn by the end of 2017. The report further projects that global sales of wood pellets will soar at a CAGR of 8.7% to bring in over US$ 21,100 Mn by the end of 2027.
The report also reveals that in 2016, approximately 37.5 million tons of wood pellets were sold across the globe. Increasing investments in new technologies & pelleting machines, coupled with higher demand for wood pellets in electricity generation, are some of the prominent trends influencing the growth of global wood pellets market during the forecast period. Apart from industrial co-firing, the market is also expected to witness higher traction in end-use offerings such as use of pellets in residential & commercial heating and i